Neurotrophic Keratopathy
Also known as: Neurotrophic Keratitis / Neurotrophic keratitis (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB13926 | Cenegermin | A recombinant human nerve growth factor used to treat neurotrophic keratitis. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB13926 | Cenegermin | High affinity nerve growth factor receptor | target |
| DB13926 | Cenegermin | Tumor necrosis factor receptor superfamily member 16 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB12620 | Nerve Growth Factor | 1 / 2 | Completed | 1 |
| DB18364 | BRM-421 | 2 | Not Yet Recruiting | 1 |
| DB13926 | Cenegermin | 2 | Completed | 1 |
| DB18013 | Udonitrectag | 2 | Recruiting | 1 |
| DB01273 | Varenicline | 2 | Completed | 1 |
| DB00030 | Insulin human | 2 / 3 | Withdrawn | 1 |
| DB12003 | Thymosin beta-4 | 3 | Recruiting | 1 |
| DB13926 | Cenegermin | 4 | Completed | 1 |
| DB00030 | Insulin human | 4 | Not Yet Recruiting | 1 |
| DB13926 | Cenegermin | Not Available | Completed | 2 |
| DB13926 | Cenegermin | Not Available | Recruiting | 3 |
| DB00030 | Insulin human | Not Available | Completed | 1 |
| DB12620 | Nerve Growth Factor | Not Available | Completed | 1 |